Proposed Changes to NHS Availability of Erectile Dysfunction Treatments

Closed 21 Mar 2014

Opened 23 Jan 2014

Overview

In 1999 the Department brought in measures to restrict NHS prescribing of a number of ED treatments, including Viagra, because they were considered too costly for routine availability on the NHS.  These restrictions mean that only certain men can have ED treatments prescribed on the NHS, for example, men with diabetes or prostate cancer.  Viagra lost its patent protection in the UK in June 2013 so generic preparations, called sildenafil, can now be marketed.  Prices have dropped by 93%. Now it is available more cheaply, we are consulting on proposals to amend the regulations to allow unrestricted prescribing of the generic drug for men suffering with ED. 

Why We Are Consulting

This consultation seeks views on our proposals to remove statutory prescribing restrictions for some generic erectile dysfunction (ED) treatments.

What Happens Next

We will analyse and respond to survey responses in March and April.

Audiences

  • Charities
  • GPs
  • Clinicians
  • Pharmacists
  • Doctors
  • NHS Commissioning Board
  • Clinical Commissioning Groups
  • Trade union
  • Patients
  • Patients
  • Suppliers

Interests

  • Sexual health
  • Well-being
  • NHS Health Checks
  • Prevention
  • Primary care
  • GP consortia
  • NHS Commissioning Board